0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Point of Care Diagnostics (POCD) Market Size, Status and Forecast 2021-2027
Published Date: November 2021
|
Report Code: QYRE-Othe-2Z478
Home | Market Reports | Health | Medical Facilities & Services
Point of Care Diagnostics Market

Global Point of Care Diagnostics (POCD) Market Size, Status and Forecast 2021-2027

Code: QYRE-Othe-2Z478
Report
November 2021
127 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Point of Care Diagnostics Market Outlook 2027

The global Point-of-Care Diagnostics market size is projected to reach US$ 35370 million by 2027, from US$ 23310 million in 2020, at a CAGR of 5.7% during 2021-2027. Point of care tests, also called near-patient testing or bedside testing, refer to the performance of diagnostic tests at or near the site where the patient is located and help in obtaining accurate results in a very short period of time.
 
The rising prevalence of chronic and infectious diseases such as heart disease, hepatitis, cancer, gastrointestinal, respiratory, and sexually transmitted diseases (STDs) is driving the Point of Care Diagnostics Market.
 
Point of Care Diagnostics Market

An increase in the number of diabetic cases is expected to drive the growth of the Point of Care Diagnostics Market. The adoption of blood glucose monitoring systems is increasing due to factors such as the growing number of diabetic patients, increased patient knowledge of the importance of blood sugar monitoring, and the development of novel monitoring devices by important players

Other key factors likely to drive the growth of the Point of Care Diagnostics Market include the rising prevalence of other respiratory illnesses around the world, the shift toward decentralized diagnostics, and improved access to point-of-care devices through online platforms.

POC testing can significantly enhance the management of infectious diseases, particularly in underdeveloped nations where prompt medical care is difficult to come by and healthcare infrastructure is lacking. Furthermore, government incentives and grants for the development of new goods are accelerating the adoption of improved diagnostic technology for infectious diseases. People in undeveloped and developing countries can now afford these tests thanks to such initiatives. During the forecast period, factors such as the increasing number of clinics implementing POC testing for the rapid identification of infectious diseases are expected to fuel Point of Care Diagnostics Market growth.

Nanotechnology integration in rapid diagnostics to drive Point of Care Diagnostics Market growth. With technological improvements, it is critical that high-quality healthcare management be implemented for fast patient care. Nanotechnology has allowed scientists to investigate a wide range of healthcare applications. Product demand will be boosted even more by the production of nanotechnology-based POC diagnostics.

COVID -19 outbreak is expected to further propel the growth of the Point of Care Diagnostics Market. Increasing usage of POC tests that can rapidly diagnose COVID-19 is being used around the world.

Point of Care Diagnostics Market Size

Point of Care Diagnostics Market Segment Review

Based on region, North America is expected to be the most lucrative region in the point of care diagnostics market. With the rising incidence and prevalence of lifestyle diseases, North America is gaining traction. Furthermore, the presence of major key players in the region, favorable government scenarios, increased awareness of self-testing and home care products, and significant adoption of novel technologies are all expected to contribute significantly to the growth of the North American point of care diagnostics market.

Based on type, the glucose monitoring segment is expected to be the most lucrative in the point of care diagnostics market. The considerable adoption of new technologies among academics and academia, the rising diabetic patient population base, and the growing preference for home glucose testing are all aspects that contribute to this segment's size.

Point of Care Diagnostics (POCD) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Diagnostics (POCD) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. 

Point of Care Diagnostics Market by Type

  • Blood Glucose Testing
  • Infectious Diseases Testing
  • Cardiac Markers Testing
  • Coagulation Testing
  • Pregnancy and Fertility Testing
  • Blood Gas/Electrolytes Testing
  • Tumor Markers Testing
  • Urinalysis Testing
  • Cholesterol Testing
  • Others

Point of Care Diagnostics Market by Application

  • Clinics
  • Hospitals
  • Assisted Living Healthcare Facilities
  • Laboratory

Point of Care Diagnostics Market by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Leading Players in the Point of Care Diagnostics Market

  • Alere
  • Roche
  • Abbott Laboratories
  • Johnson & Johnson
  • Siemens Healthcare
  • Danaher
  • QIAGEN
  • Bayer Healthcare
  • Beckman Coulter
  • Nipro Diagnostics
  • Bio-Rad Laboratories
  • Nova Biomedical
  • BioMerieux
  • Quidel
  • Helena Laboratories
  • OraSure Technologies
  • Accriva
  • Abaxis
  • Chembio Diagnostics
  • Trinity Biotech
  • Instrumentation Laboratory
  • Sekisui Diagnostics

Scope of the Point of Care Diagnostics Market Report

Report Metric

Details

Report Name

Point of Care Diagnostics Market

The market size in 2020

USD 23310 Million

The revenue forecast in 2027

USD 35370 Million

Growth Rate

Compound Annual Growth Rate (CAGR) of 5.7% from 2021 to 2027

Market size available for years

2021-2027

Forecast units

Value (USD)

Segments covered

Type, End-User, Offerings, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. What will be the global Point of Care Diagnostics Market size from 2020 to 2027?

Ans. The global Point of Care Diagnostics Market size is projected to reach US$ 35370 million by 2027, from US$ 23310 million in 2020

2. What is the growth rate of the global Point of Care Diagnostics Market during the forecast period?

Ans. The global Point of Care Diagnostics Market is estimated to grow with a CAGR of 5.7% during the forecast period

3. What are the upcoming trends or opportunities in the Point of Care Diagnostics Market?

Ans. An increase in the number of diabetic cases is expected to drive the growth of the Point of Care Diagnostics Market. Moreover, the technological developments in POC devices, as well as increased investments by key players, are propelling the Point of Care Diagnostics Market forward.

4. Which region witnesses to have a lucrative market?

Ans. Based on region, North America is expected to be the most lucrative region in the point of care diagnostics market.

5. Does the report provide COVID-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Tumor Markers Testing
1.2.9 Urinalysis Testing
1.2.10 Cholesterol Testing
1.2.11 Others
1.3 Market by Application
1.3.1 Global Point of Care Diagnostics (POCD) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Assisted Living Healthcare Facilities
1.3.5 Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Point of Care Diagnostics (POCD) Market Perspective (2016-2027)
2.2 Point of Care Diagnostics (POCD) Growth Trends by Regions
2.2.1 Point of Care Diagnostics (POCD) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Point of Care Diagnostics (POCD) Historic Market Share by Regions (2016-2021)
2.2.3 Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2022-2027)
2.3 Point of Care Diagnostics (POCD) Industry Dynamic
2.3.1 Point of Care Diagnostics (POCD) Market Trends
2.3.2 Point of Care Diagnostics (POCD) Market Drivers
2.3.3 Point of Care Diagnostics (POCD) Market Challenges
2.3.4 Point of Care Diagnostics (POCD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue
3.1.1 Global Top Point of Care Diagnostics (POCD) Players by Revenue (2016-2021)
3.1.2 Global Point of Care Diagnostics (POCD) Revenue Market Share by Players (2016-2021)
3.2 Global Point of Care Diagnostics (POCD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Point of Care Diagnostics (POCD) Revenue
3.4 Global Point of Care Diagnostics (POCD) Market Concentration Ratio
3.4.1 Global Point of Care Diagnostics (POCD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Point of Care Diagnostics (POCD) Revenue in 2020
3.5 Point of Care Diagnostics (POCD) Key Players Head office and Area Served
3.6 Key Players Point of Care Diagnostics (POCD) Product Solution and Service
3.7 Date of Enter into Point of Care Diagnostics (POCD) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Point of Care Diagnostics (POCD) Breakdown Data by Type
4.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Type (2016-2021)
4.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2022-2027)
5 Point of Care Diagnostics (POCD) Breakdown Data by Application
5.1 Global Point of Care Diagnostics (POCD) Historic Market Size by Application (2016-2021)
5.2 Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Point of Care Diagnostics (POCD) Market Size (2016-2027)
6.2 North America Point of Care Diagnostics (POCD) Market Size by Type
6.2.1 North America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
6.2.2 North America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
6.2.3 North America Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
6.3 North America Point of Care Diagnostics (POCD) Market Size by Application
6.3.1 North America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
6.3.2 North America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
6.3.3 North America Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
6.4 North America Point of Care Diagnostics (POCD) Market Size by Country
6.4.1 North America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
6.4.2 North America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Point of Care Diagnostics (POCD) Market Size (2016-2027)
7.2 Europe Point of Care Diagnostics (POCD) Market Size by Type
7.2.1 Europe Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
7.2.2 Europe Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
7.2.3 Europe Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
7.3 Europe Point of Care Diagnostics (POCD) Market Size by Application
7.3.1 Europe Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
7.3.2 Europe Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
7.3.3 Europe Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
7.4 Europe Point of Care Diagnostics (POCD) Market Size by Country
7.4.1 Europe Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
7.4.2 Europe Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size (2016-2027)
8.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type
8.2.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
8.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application
8.3.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
8.4 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region
8.4.1 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Point of Care Diagnostics (POCD) Market Size (2016-2027)
9.2 Latin America Point of Care Diagnostics (POCD) Market Size by Type
9.2.1 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
9.2.2 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
9.2.3 Latin America Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
9.3 Latin America Point of Care Diagnostics (POCD) Market Size by Application
9.3.1 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
9.3.2 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
9.3.3 Latin America Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
9.4 Latin America Point of Care Diagnostics (POCD) Market Size by Country
9.4.1 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
9.4.2 Latin America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size (2016-2027)
10.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type
10.2.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2016-2027)
10.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application
10.3.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2016-2027)
10.4 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country
10.4.1 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alere
11.1.1 Alere Company Details
11.1.2 Alere Business Overview
11.1.3 Alere Point of Care Diagnostics (POCD) Introduction
11.1.4 Alere Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.1.5 Alere Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Point of Care Diagnostics (POCD) Introduction
11.2.4 Roche Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Point of Care Diagnostics (POCD) Introduction
11.3.4 Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Point of Care Diagnostics (POCD) Introduction
11.4.4 Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Siemens Healthcare
11.5.1 Siemens Healthcare Company Details
11.5.2 Siemens Healthcare Business Overview
11.5.3 Siemens Healthcare Point of Care Diagnostics (POCD) Introduction
11.5.4 Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.5.5 Siemens Healthcare Recent Development
11.6 Danaher
11.6.1 Danaher Company Details
11.6.2 Danaher Business Overview
11.6.3 Danaher Point of Care Diagnostics (POCD) Introduction
11.6.4 Danaher Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.6.5 Danaher Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Point of Care Diagnostics (POCD) Introduction
11.7.4 QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.7.5 QIAGEN Recent Development
11.8 Bayer Healthcare
11.8.1 Bayer Healthcare Company Details
11.8.2 Bayer Healthcare Business Overview
11.8.3 Bayer Healthcare Point of Care Diagnostics (POCD) Introduction
11.8.4 Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.8.5 Bayer Healthcare Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Details
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Point of Care Diagnostics (POCD) Introduction
11.9.4 Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.9.5 Beckman Coulter Recent Development
11.10 Nipro Diagnostics
11.10.1 Nipro Diagnostics Company Details
11.10.2 Nipro Diagnostics Business Overview
11.10.3 Nipro Diagnostics Point of Care Diagnostics (POCD) Introduction
11.10.4 Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.10.5 Nipro Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Details
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Point of Care Diagnostics (POCD) Introduction
11.11.4 Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 Nova Biomedical
11.12.1 Nova Biomedical Company Details
11.12.2 Nova Biomedical Business Overview
11.12.3 Nova Biomedical Point of Care Diagnostics (POCD) Introduction
11.12.4 Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.12.5 Nova Biomedical Recent Development
11.13 BioMerieux
11.13.1 BioMerieux Company Details
11.13.2 BioMerieux Business Overview
11.13.3 BioMerieux Point of Care Diagnostics (POCD) Introduction
11.13.4 BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.13.5 BioMerieux Recent Development
11.14 Quidel
11.14.1 Quidel Company Details
11.14.2 Quidel Business Overview
11.14.3 Quidel Point of Care Diagnostics (POCD) Introduction
11.14.4 Quidel Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.14.5 Quidel Recent Development
11.15 Helena Laboratories
11.15.1 Helena Laboratories Company Details
11.15.2 Helena Laboratories Business Overview
11.15.3 Helena Laboratories Point of Care Diagnostics (POCD) Introduction
11.15.4 Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.15.5 Helena Laboratories Recent Development
11.16 OraSure Technologies
11.16.1 OraSure Technologies Company Details
11.16.2 OraSure Technologies Business Overview
11.16.3 OraSure Technologies Point of Care Diagnostics (POCD) Introduction
11.16.4 OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.16.5 OraSure Technologies Recent Development
11.17 Accriva
11.17.1 Accriva Company Details
11.17.2 Accriva Business Overview
11.17.3 Accriva Point of Care Diagnostics (POCD) Introduction
11.17.4 Accriva Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.17.5 Accriva Recent Development
11.18 Abaxis
11.18.1 Abaxis Company Details
11.18.2 Abaxis Business Overview
11.18.3 Abaxis Point of Care Diagnostics (POCD) Introduction
11.18.4 Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.18.5 Abaxis Recent Development
11.18 Chembio Diagnostics
.1 Chembio Diagnostics Company Details
.2 Chembio Diagnostics Business Overview
.3 Chembio Diagnostics Point of Care Diagnostics (POCD) Introduction
.4 Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
.5 Chembio Diagnostics Recent Development
11.20 Trinity Biotech
11.20.1 Trinity Biotech Company Details
11.20.2 Trinity Biotech Business Overview
11.20.3 Trinity Biotech Point of Care Diagnostics (POCD) Introduction
11.20.4 Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.20.5 Trinity Biotech Recent Development
11.21 Instrumentation Laboratory
11.21.1 Instrumentation Laboratory Company Details
11.21.2 Instrumentation Laboratory Business Overview
11.21.3 Instrumentation Laboratory Point of Care Diagnostics (POCD) Introduction
11.21.4 Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.21.5 Instrumentation Laboratory Recent Development
11.22 Sekisui Diagnostics
11.22.1 Sekisui Diagnostics Company Details
11.22.2 Sekisui Diagnostics Business Overview
11.22.3 Sekisui Diagnostics Point of Care Diagnostics (POCD) Introduction
11.22.4 Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021)
11.22.5 Sekisui Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Point of Care Diagnostics (POCD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Blood Glucose Testing
    Table 3. Key Players of Infectious Diseases Testing
    Table 4. Key Players of Cardiac Markers Testing
    Table 5. Key Players of Coagulation Testing
    Table 6. Key Players of Pregnancy and Fertility Testing
    Table 7. Key Players of Blood Gas/Electrolytes Testing
    Table 8. Key Players of Tumor Markers Testing
    Table 9. Key Players of Urinalysis Testing
    Table 10. Key Players of Cholesterol Testing
    Table 11. Key Players of Others
    Table 12. Global Point of Care Diagnostics (POCD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 13. Global Point of Care Diagnostics (POCD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 14. Global Point of Care Diagnostics (POCD) Market Size by Regions (2016-2021) & (US$ Million)
    Table 15. Global Point of Care Diagnostics (POCD) Market Share by Regions (2016-2021)
    Table 16. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 17. Global Point of Care Diagnostics (POCD) Market Share by Regions (2022-2027)
    Table 18. Point of Care Diagnostics (POCD) Market Trends
    Table 19. Point of Care Diagnostics (POCD) Market Drivers
    Table 20. Point of Care Diagnostics (POCD) Market Challenges
    Table 21. Point of Care Diagnostics (POCD) Market Restraints
    Table 22. Global Point of Care Diagnostics (POCD) Revenue by Players (2016-2021) & (US$ Million)
    Table 23. Global Point of Care Diagnostics (POCD) Market Share by Players (2016-2021)
    Table 24. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2020)
    Table 25. Ranking of Global Top Point of Care Diagnostics (POCD) Companies by Revenue (US$ Million) in 2020
    Table 26. Global 5 Largest Players Market Share by Point of Care Diagnostics (POCD) Revenue (CR5 and HHI) & (2016-2021)
    Table 27. Key Players Headquarters and Area Served
    Table 28. Key Players Point of Care Diagnostics (POCD) Product Solution and Service
    Table 29. Date of Enter into Point of Care Diagnostics (POCD) Market
    Table 30. Mergers & Acquisitions, Expansion Plans
    Table 31. Global Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 32. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2016-2021)
    Table 33. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 34. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 35. Global Point of Care Diagnostics (POCD) Market Size Share by Application (2016-2021) & (US$ Million)
    Table 36. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2016-2021)
    Table 37. Global Point of Care Diagnostics (POCD) Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 38. Global Point of Care Diagnostics (POCD) Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 39. North America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 40. North America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 41. North America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 42. North America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 43. North America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million)
    Table 44. North America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million)
    Table 45. Europe Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 46. Europe Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Europe Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 48. Europe Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Europe Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million)
    Table 50. Europe Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million)
    Table 51. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 52. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 54. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2016-2021) & (US$ Million)
    Table 56. Asia-Pacific Point of Care Diagnostics (POCD) Market Size by Region (2022-2027) & (US$ Million)
    Table 57. Latin America Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 58. Latin America Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Latin America Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 60. Latin America Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million)
    Table 62. Latin America Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million)
    Table 63. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2016-2021) (US$ Million)
    Table 64. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Type (2022-2027) & (US$ Million)
    Table 65. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2016-2021) (US$ Million)
    Table 66. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Application (2022-2027) & (US$ Million)
    Table 67. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2016-2021) & (US$ Million)
    Table 68. Middle East & Africa Point of Care Diagnostics (POCD) Market Size by Country (2022-2027) & (US$ Million)
    Table 69. Alere Company Details
    Table 70. Alere Business Overview
    Table 71. Alere Point of Care Diagnostics (POCD) Product
    Table 72. Alere Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 73. Alere Recent Development
    Table 74. Roche Company Details
    Table 75. Roche Business Overview
    Table 76. Roche Point of Care Diagnostics (POCD) Product
    Table 77. Roche Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 78. Roche Recent Development
    Table 79. Abbott Laboratories Company Details
    Table 80. Abbott Laboratories Business Overview
    Table 81. Abbott Laboratories Point of Care Diagnostics (POCD) Product
    Table 82. Abbott Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 83. Abbott Laboratories Recent Development
    Table 84. Johnson & Johnson Company Details
    Table 85. Johnson & Johnson Business Overview
    Table 86. Johnson & Johnson Point of Care Diagnostics (POCD) Product
    Table 87. Johnson & Johnson Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 88. Johnson & Johnson Recent Development
    Table 89. Siemens Healthcare Company Details
    Table 90. Siemens Healthcare Business Overview
    Table 91. Siemens Healthcare Point of Care Diagnostics (POCD) Product
    Table 92. Siemens Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 93. Siemens Healthcare Recent Development
    Table 94. Danaher Company Details
    Table 95. Danaher Business Overview
    Table 96. Danaher Point of Care Diagnostics (POCD) Product
    Table 97. Danaher Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 98. Danaher Recent Development
    Table 99. QIAGEN Company Details
    Table 100. QIAGEN Business Overview
    Table 101. QIAGEN Point of Care Diagnostics (POCD) Product
    Table 102. QIAGEN Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 103. QIAGEN Recent Development
    Table 104. Bayer Healthcare Company Details
    Table 105. Bayer Healthcare Business Overview
    Table 106. Bayer Healthcare Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 107. Bayer Healthcare Recent Development
    Table 108. Beckman Coulter Company Details
    Table 109. Beckman Coulter Business Overview
    Table 110. Beckman Coulter Point of Care Diagnostics (POCD) Product
    Table 111. Beckman Coulter Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 112. Beckman Coulter Recent Development
    Table 113. Nipro Diagnostics Company Details
    Table 114. Nipro Diagnostics Business Overview
    Table 115. Nipro Diagnostics Point of Care Diagnostics (POCD) Product
    Table 116. Nipro Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 117. Nipro Diagnostics Recent Development
    Table 118. Bio-Rad Laboratories Company Details
    Table 119. Bio-Rad Laboratories Business Overview
    Table 120. Bio-Rad Laboratories Point of Care Diagnostics (POCD) Product
    Table 121. Bio-Rad Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 122. Bio-Rad Laboratories Recent Development
    Table 123. Nova Biomedical Company Details
    Table 124. Nova Biomedical Business Overview
    Table 125. Nova Biomedical Point of Care Diagnostics (POCD) Product
    Table 126. Nova Biomedical Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 127. Nova Biomedical Recent Development
    Table 128. BioMerieux Company Details
    Table 129. BioMerieux Business Overview
    Table 130. BioMerieux Point of Care Diagnostics (POCD) Product
    Table 131. BioMerieux Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 132. BioMerieux Recent Development
    Table 133. Quidel Company Details
    Table 134. Quidel Business Overview
    Table 135. Quidel Point of Care Diagnostics (POCD) Product
    Table 136. Quidel Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 137. Quidel Recent Development
    Table 138. Helena Laboratories Company Details
    Table 139. Helena Laboratories Business Overview
    Table 140. Helena Laboratories Point of Care Diagnostics (POCD) Product
    Table 141. Helena Laboratories Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 142. Helena Laboratories Recent Development
    Table 143. OraSure Technologies Company Details
    Table 144. OraSure Technologies Business Overview
    Table 145. OraSure Technologies Point of Care Diagnostics (POCD) Product
    Table 146. OraSure Technologies Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 147. OraSure Technologies Recent Development
    Table 148. Accriva Company Details
    Table 149. Accriva Business Overview
    Table 150. Accriva Point of Care Diagnostics (POCD) Product
    Table 151. Accriva Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 152. Accriva Recent Development
    Table 153. Abaxis Company Details
    Table 154. Abaxis Business Overview
    Table 155. Abaxis Point of Care Diagnostics (POCD) Product
    Table 156. Abaxis Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 157. Abaxis Recent Development
    Table 158. Chembio Diagnostics Company Details
    Table 159. Chembio Diagnostics Business Overview
    Table 160. Chembio Diagnostics Point of Care Diagnostics (POCD) Product
    Table 161. Chembio Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 162. Chembio Diagnostics Recent Development
    Table 163. Trinity Biotech Company Details
    Table 164. Trinity Biotech Business Overview
    Table 165. Trinity Biotech Point of Care Diagnostics (POCD) Product
    Table 166. Trinity Biotech Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 167. Trinity Biotech Recent Development
    Table 168. Instrumentation Laboratory Company Details
    Table 169. Instrumentation Laboratory Business Overview
    Table 170. Instrumentation Laboratory Point of Care Diagnostics (POCD) Product
    Table 171. Instrumentation Laboratory Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 172. Instrumentation Laboratory Recent Development
    Table 173. Sekisui Diagnostics Company Details
    Table 174. Sekisui Diagnostics Business Overview
    Table 175. Sekisui Diagnostics Point of Care Diagnostics (POCD) Product
    Table 176. Sekisui Diagnostics Revenue in Point of Care Diagnostics (POCD) Business (2016-2021) & (US$ Million)
    Table 177. Sekisui Diagnostics Recent Development
    Table 178. Research Programs/Design for This Report
    Table 179. Key Data Information from Secondary Sources
    Table 180. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Point of Care Diagnostics (POCD) Market Share by Type: 2020 VS 2027
    Figure 2. Blood Glucose Testing Features
    Figure 3. Infectious Diseases Testing Features
    Figure 4. Cardiac Markers Testing Features
    Figure 5. Coagulation Testing Features
    Figure 6. Pregnancy and Fertility Testing Features
    Figure 7. Blood Gas/Electrolytes Testing Features
    Figure 8. Tumor Markers Testing Features
    Figure 9. Urinalysis Testing Features
    Figure 10. Cholesterol Testing Features
    Figure 11. Others Features
    Figure 12. Global Point of Care Diagnostics (POCD) Market Share by Application: 2020 VS 2027
    Figure 13. Clinics Case Studies
    Figure 14. Hospitals Case Studies
    Figure 15. Assisted Living Healthcare Facilities Case Studies
    Figure 16. Laboratory Case Studies
    Figure 17. Point of Care Diagnostics (POCD) Report Years Considered
    Figure 18. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 19. Global Point of Care Diagnostics (POCD) Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 20. Global Point of Care Diagnostics (POCD) Market Share by Regions: 2020 VS 2027
    Figure 21. Global Point of Care Diagnostics (POCD) Market Share by Regions (2022-2027)
    Figure 22. Global Point of Care Diagnostics (POCD) Market Share by Players in 2020
    Figure 23. Global Top Point of Care Diagnostics (POCD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Point of Care Diagnostics (POCD) as of 2020
    Figure 24. The Top 10 and 5 Players Market Share by Point of Care Diagnostics (POCD) Revenue in 2020
    Figure 25. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2016-2021)
    Figure 26. Global Point of Care Diagnostics (POCD) Revenue Market Share by Type (2022-2027)
    Figure 27. North America Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. North America Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 29. North America Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 30. North America Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 31. United States Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Canada Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Europe Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 35. Europe Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 36. Europe Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 37. Germany Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. France Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. U.K. Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Italy Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Russia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Nordic Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 45. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 46. Asia-Pacific Point of Care Diagnostics (POCD) Market Share by Region (2016-2027)
    Figure 47. China Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Japan Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. South Korea Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Southeast Asia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. India Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Australia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Latin America Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 55. Latin America Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 56. Latin America Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 57. Mexico Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Brazil Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Type (2016-2027)
    Figure 61. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Application (2016-2027)
    Figure 62. Middle East & Africa Point of Care Diagnostics (POCD) Market Share by Country (2016-2027)
    Figure 63. Turkey Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Saudi Arabia Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. UAE Point of Care Diagnostics (POCD) Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 66. Alere Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 67. Roche Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 68. Abbott Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 69. Johnson & Johnson Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 70. Siemens Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 71. Danaher Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 72. QIAGEN Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 73. Bayer Healthcare Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 74. Beckman Coulter Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 75. Nipro Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 76. Bio-Rad Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 77. Nova Biomedical Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 78. BioMerieux Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 79. Quidel Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 80. Helena Laboratories Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 81. OraSure Technologies Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 82. Accriva Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 83. Abaxis Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 84. Chembio Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 85. Trinity Biotech Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 86. Instrumentation Laboratory Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 87. Sekisui Diagnostics Revenue Growth Rate in Point of Care Diagnostics (POCD) Business (2016-2021)
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows maximum 5 users to access the PDF

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global Influenza Diagnostics Market Insights and Forecast to 2028
Global Influenza Diagnostics Market Insights and Forecast to 2028

The global Influenza Diagnostics market size is projected to reach US 3599.9 million by 2028 from US 2335.5 million in 2021 at a CAGR of 6.3 during 20222028.Global Influenza Diagnostics Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-19G9270
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Travelers Vaccines Market Insights and Forecast to 2028
Global Travelers Vaccines Market Insights and Forecast to 2028

While Tourists segment is altered to an CAGR throughout this forecast period.Global Travelers Vaccines Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-26U371
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Blood Transfusion Market Insights and Forecast to 2028
Global Blood Transfusion Market Insights and Forecast to 2028

In the report we counted the Blood Transfusion set.Market Analysis and Insights Global Blood Transfusion MarketDue to the COVID19 pandemic the global Blood Transfusion market size is estimated to be worth US 88 million in 2022 and is forecast to a readjusted size of US 107.1 million by 2028 with a CAGR of 3.3 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24B412
Sun Jan 09 00:00:00 UTC 2022

Add to Cart

Global Surgical Robotics Market Insights and Forecast to 2028
Global Surgical Robotics Market Insights and Forecast to 2028

A surgical robot t allows surgeons greater access to areas under operation using more precise and less invasive methods.Surgical robots can assist surgery like Laparoscopy Orthopedics Neurology etc.Market Analysis and Insights Global Surgical Robotics MarketDue to the COVID19 pandemic the global Surgical Robotics market size is estimated to be worth US million in 2022 and is forecast to a readjusted size of US million by 2028 with a CAGR of during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-39T9022
Fri Jan 07 00:00:00 UTC 2022

Add to Cart